FDA Drug recall D-0388-2024
Telmisartan Tablets, USP 40mg, Rx Only, 30 Tablets per bottle, Manufactured by: Micro Labs Limited Goa-403 722, INDIA, Manufactured for: Mi…
- FDA Drug
- Class II
- terminated
- Published 2024-03-20
On 2024-03-20 the FDA classified a Class II recall of Telmisartan Tablets, USP 40mg, Rx Only, 30 Tablets per bottle, Manufactured by: Micro Labs Limited Goa-403 722, INDIA, Manufactured for: Mi… by Micro Labs, citing failed Stability Specifications: Out of specification for blend uniformity.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0388-2024 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2024-02-09 |
| Published | 2024-03-20 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Micro Labs |
| Distribution | PR, RI, TN |
Product
Telmisartan Tablets, USP 40mg, Rx Only, 30 Tablets per bottle, Manufactured by: Micro Labs Limited Goa-403 722, INDIA, Manufactured for: Micro Labs USA Inc., Somerset, NJ 08873, NDC 42571-227-30.
Reason
Failed Stability Specifications: Out of specification for blend uniformity.
Identifiers
| code_info | Lot #s: SFBG024, SFBG025, Exp. 05/31/2024 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0388-2024%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.